- Home
- MREO vs ASA Comparison
MREO vs ASA Comparison
Compare MREO & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- ASA
- Stock Information
- Founded
- MREO 2015
- ASA 1958
- Country
- MREO United Kingdom
- ASA United States
- Employees
- MREO N/A
- ASA N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- ASA Precious Metals
- Sector
- MREO Health Care
- ASA Industrials
- Exchange
- MREO Nasdaq
- ASA Nasdaq
- Market Cap
- MREO 482.5M
- ASA 415.9M
- IPO Year
- MREO N/A
- ASA N/A
- Fundamental
- Price
- MREO $2.50
- ASA $26.64
- Analyst Decision
- MREO Strong Buy
- ASA
- Analyst Count
- MREO 6
- ASA 0
- Target Price
- MREO $7.83
- ASA N/A
- AVG Volume (30 Days)
- MREO 1.5M
- ASA 48.4K
- Earning Date
- MREO 03-26-2025
- ASA 03-25-2025
- Dividend Yield
- MREO N/A
- ASA 0.15%
- EPS Growth
- MREO N/A
- ASA 1102.63
- EPS
- MREO N/A
- ASA 6.06
- Revenue
- MREO $1,000,000.00
- ASA $2,140,037.00
- Revenue This Year
- MREO N/A
- ASA N/A
- Revenue Next Year
- MREO N/A
- ASA N/A
- P/E Ratio
- MREO N/A
- ASA $4.27
- Revenue Growth
- MREO N/A
- ASA N/A
- 52 Week Low
- MREO $2.25
- ASA $14.55
- 52 Week High
- MREO $5.02
- ASA $26.80
- Technical
- Relative Strength Index (RSI)
- MREO 38.26
- ASA 63.58
- Support Level
- MREO $2.39
- ASA $24.57
- Resistance Level
- MREO $2.59
- ASA $26.02
- Average True Range (ATR)
- MREO 0.17
- ASA 0.89
- MACD
- MREO 0.02
- ASA 0.02
- Stochastic Oscillator
- MREO 39.87
- ASA 96.10
Stock Price Comparison Chart: MREO vs ASA
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.